Real Life Data and Outcome of FOLFIRINOX Use in Metastatic Pancreatic Cancer Patients in General Hospitals in the Netherlands by Haberkorn, B.C.M., Hoogendijk, L., Loosveld, O.S., Thijs, A. M. J., Verstijnen, J.

Get full text

Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer by Reesink, Daan J., van Melick, Harm H. E., van der Nat, Paul B., Los, Maartje, Horenblas, Simon, van de Garde, Ewoudt M. W.

Get full text

Hospital variation in treatment patterns and oncological outcomes for patients with muscle-invasive and metastatic bladder cancer in the Netherlands by Reesink, Daan J., van de Garde, Ewoudt M. W., van der Nat, Paul, Somford, Diederik M., Los, Maartje, Horenblas, Simon, van Melick, Harm H. E.

Get full text

Response to chemotherapy in patients with recurrent rectal cancer in previously irradiated area by Alberda, W. J., Haberkorn, B. C., Morshuis, W. G., Oudendijk, J. F., Nuyttens, J. J., Burger, J. W. A., Verhoef, C., van Meerten, E.

Get full text

Circulating TP53 mutations are predictive and prognostic biomarkers in pancreatic cancer patients treated with FOLFIRINOX chemotherapy by Van Der Sijde, F., Azmani, Z., Besselink, M., Bonsing, B., de Groot, J.W., Koerkamp, B. Groot, Haberkorn, B., Homs, M., van Ijcken, W., Janssen, Q., Lolkema, M., Luelmo, S., Mekenkamp, L., Mustafa, D., van Schaik, R., Wilmink, J., van Eijck, C., Vietsch, E.

Get full text

Uitkomsten in de dagelijkse praktijk van eerstelijnschemotherapie voor niet-resectabel stadium III en IV urotheelcarcinoom van de blaas by Reesink, Daan J., van de Garde, Ewoudt M. W., van der Nat, Paul B., Los, Maartje, Horenblas, Simon, van Melick, Harm H. E.

Get full text

Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study by de Joode, Karlijn, Dumoulin, Daphne W., Tol, Jolien, Westgeest, Hans M., Beerepoot, Laurens V., van den Berkmortel, Franchette W.P.J., Mutsaers, Pim G.N.J., van Diemen, Nico G.J., Visser, Otto J., Oomen-de Hoop, Esther, Bloemendal, Haiko J., van Laarhoven, Hanneke W.M., Hendriks, Lizza E.L., Haanen, John B.A.G., de Vries, Elisabeth G.E., Dingemans, Anne-Marie C., van der Veldt, Astrid A.M., van Loenhout, C.J., van der Leest, C.H., Becker-Commissaris, A., Borgers, J.S.W., Terhegggen, F., van den Borne, B.E.E.M., van Warmerdam, L.J.C., van Leeuwen, L., van der Meer, F.S., Tiemessen, M.A., van Diepen, D.M., Klaver, Y., Hamberg, A.P., Libourel, E.J., Strobbe, L., Cloos, M., Geraedts, E.J., Drooger, J.C., Heller, R., de Groot, J.W.B., Stigt, J.A., Nuij, V.J.A.A., Pitz, C.C.M., Slingerland, M., Borm, F.J., Haberkorn, B.C.M., Westeinde, S.C. van 't, Aarts, M.J.B., van Putten, J.W.G., Youssef, M., Cirkel, G.A., Herder, G.J.M., van Rooijen, C.R., Citgez, E., Barlo, N.P., Scholtes, B.M.J., Koornstra, R.H.T., Claessens, N.J.M., Faber, L.M., Rikers, C.H., van de Wetering, R.A.W., Veurink, G.L., Bouter, B.W., Houtenbos, I., Bard, M.P.L., Herbschleb, K.H., Kastelijn, E.A., Brocken, P., Douma, G., Jalving, M., Hiltermann, T.J.N., Schuurbiers-Siebers, O.C.J., Suijkerbuijk, K.P.M., van Lindert, A.S.R., van de Wouw, A.J., van den Boogaart, V.E.M., Bakker, S.D., Looysen, E., Peerdeman, A.L., de Jong, W.K., Siemerink, E.J.M., Staal, A.J., Franken, B., van Geffen, W.H., Bootsma, G.P.

Get full text

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer by Dekker, E. N, Busch, O. R, Labori, K. J, Haberkorn, B. C. M, van der Holt, B, Wilmink, J. W, Feshtali, S, Besselink, M. G, van Eijck, C. H. J, van Tienhoven, G, van der Kolk, M. B, van Dam, J. L, Bratlie, S. O, Liem, M. S. L, de Hingh, I. H, Homs, M. Y. V, de Vos - Geelen, J, de Groot, J. W. B, Polée, M. B, de Groot, D. J. A, van Santvoort, H. C, Bonsing, B. A, Verkolf, E. M. M, Karsten, T. M, Groot Koerkamp, B, Ghorbani, P, van Driel, L. M. J. W, Molenaar, I. Q, Brosens, L. A. A, Loosveld, O. J. L, Wumkes, M. L

Get full text

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium by de Joode, Karlijn, Tol, Jolien, Hamberg, Paul, Cloos, Marissa, Kastelijn, Elisabeth A., Borgers, Jessica S.W., Nuij, Veerle J.A.A., Klaver, Yarne, Herder, Gerarda J.M., Mutsaers, Pim G.N.J., Dumoulin, Daphne W., Oomen-de Hoop, Esther, van Diemen, Nico G.J., Libourel, Eduard J., Geraedts, Erica J., Bootsma, Gerben P., van der Leest, Cor H., Peerdeman, Anne L., Herbschleb, Karin H., Visser, Otto J., Bloemendal, Haiko J., van Laarhoven, Hanneke W.M., de Vries, Elisabeth G.E., Hendriks, Lizza E.L., Beerepoot, Laurens V., Westgeest, Hans M., van den Berkmortel, Franchette W.P.J., Haanen, John B.A.G., Dingemans, Anne-Marie C., van der Veldt, Astrid A.M., Becker-Commissaris, A., Terheggen, F., van den Borne, B.E.E.M., van Warmerdam, L.J.C., van Leeuwen, L., van der Meer, F.S., Tiemessen, M.A., van Diepen, D.M., Strobbe, L., Koekkoek, J.A.F., Brocken, P., Drooger, J.C., Heller, R., de Groot, J.W.B., Stigt, J.A., Pitz, C.C.M., Slingerland, M., Borm, F.J., Haberkorn, B.C.M., van 't Westeinde, S.C., Aarts, M.J.B., van Putten, J.W.G., Youssef, M., Cirkel, G.A., van Rooijen, C.R., Citgez, E., Barlo, N.P., Scholtes, B.M.J., Koornstra, R.H.T., Claessens, N.J.M., Faber, L.M., Rikers, C.H., van de Wetering, R.A.W., Veurink, G.L., Bouter, B.W., Houtenbos, I., Bard, M.P.L., Douma, G., Jalving, M., Hiltermann, T.J.N., Schuurbiers-Siebers, O.C.J., Suijkerbuijk, K.P.M., van Lindert, A.S.R., van de Wouw, A.J., van den Boogaart, V.E.M., Bakker, S.D., Looysen, E., de Jong, W.K., Siemerink, E.J.M., Staal, A.J., Franken, B., van Geffen, W.H.

Get full text

Impact of a Sex and Comprehensive Anxiolytic Approach on Scan Duration and Image Quality During Cardiac MRI Acquisition by Houston, Angel, Haberkorn, Sarah, Eck, Brendan, Loviscek, Darcy, Obuchowski, Nancy, Reece, Christine, Flamm, Scott, Nguyen, Christopher, Kwon, Deborah

Get full text

Impact of Aromatherapy as an Alternative Anxiolytic Therapy on Scan Time and Nursing Interventions for Patients Undergoing Cardiac MRI by Houston, Angel, Haberkorn, Sarah, Loviscek, Darcy, Obuchowski, Nancy, Ward, Leah, Shauntia, Cabot, Corcoran, Erich, Joan, Weaver, Lewis, Branda, Videc, Lindsey, Steve, Rayer, Pukanski, Nataliya, Zak, Katherina, Schoenhagen, Paul, Bolen, Michael, Reece, Christine, Videc, Branda Lewis Lindsey, Nguyen, Christopher, Kwon, Deborah, Eck, Brendan

Get full text

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial by van Dam, J L, Verkolf, E M M, Dekker, E N, Bonsing, B A, Bratlie, S O, Brosens, L A A, Busch, O R, van Driel, L M J W, van Eijck, C H J, Feshtali, S, Ghorbani, P, de Groot, D J A, de Groot, J W B, Haberkorn, B C M, de Hingh, I H, van der Holt, B, Karsten, T M, van der Kolk, M B, Labori, K J, Liem, M S L, Loosveld, O J L, Molenaar, I Q, Polée, M B, van Santvoort, H C, de Vos-Geelen, J, Wumkes, M L, van Tienhoven, G, Homs, M Y V, Besselink, M G, Wilmink, J W, Groot Koerkamp, B

Get full text

Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trial by Mackay, T M, Smits, F J, Latenstein, A E J, Bogte, A, Bonsing, B A, Bos, H, Bosscha, K, Brosens, L A A, Hol, L, Busch, O R C, Creemers, G J, Curvers, W L, den Dulk, M, van Dieren, S, van Driel, L M J W, Festen, S, van Geenen, E J M, van der Geest, L G, de Groot, D J A, de Groot, J W B, Haj Mohammad, N, Haberkorn, B C M, Haver, J T, van der Harst, E, Hemmink, G J M, de Hingh, I H, Hoge, C, Homs, M Y V, van Huijgevoort, N C, Jacobs, M A J M, Kerver, E D, Liem, M S L, Los, M, Lubbinge, H, Luelmo, S A C, de Meijer, V E, Mekenkamp, L, Molenaar, I Q, van Oijen, M G H, Patijn, G A, Quispel, R, van Rijssen, L B, Römkens, T E H, van Santvoort, H C, Schreinemakers, J M J, Schut, H, Seerden, T, Stommel, M W J, Ten Tije, A J, Venneman, N G, Verdonk, R C, Verheij, J, van Vilsteren, F G I, de Vos-Geelen, J, Vulink, A, Wientjes, C, Wit, F, Wessels, F J, Zonderhuis, B, van Werkhoven, C H, van Hooft, J E, van Eijck, C H J, Wilmink, J W, van Laarhoven, H W M, Besselink, M G

Get full text

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial by van Dam, J. L, Verkolf, E. M. M, Dekker, E. N, Bonsing, B. A, Bratlie, S. O, Brosens, L. A. A, Busch, O. R, van Driel, L. M. J. W, van Eijck, C. H. J, Feshtali, S, Ghorbani, P, de Groot, D. J. A, de Groot, J. W. B, Haberkorn, B. C. M, de Hingh, I. H, van der Holt, B, Karsten, T. M, van der Kolk, M. B, Labori, K. J, Liem, M. S. L, Loosveld, O. J. L, Molenaar, I. Q, Polée, M. B, van Santvoort, H. C, de Vos – Geelen, J, Wumkes, M. L, van Tienhoven, G, Homs, M. Y. V, Besselink, M. G, Wilmink, J. W, Groot Koerkamp, B

Request full text

F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients by Giesel, Frederik L., Hadaschik, B., Cardinale, J., Radtke, J., Vinsensia, M., Lehnert, W., Kesch, C., Tolstov, Y., Singer, S., Grabe, N., Duensing, S., Schäfer, M., Neels, O. C., Mier, W., Haberkorn, U., Kopka, K., Kratochwil, C.

Get full text

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions by Afshar-Oromieh, A., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Hadaschik, B. A., Holland-Letz, T., Giesel, F. L., Kratochwil, C., Haufe, S., Haberkorn, U., Zechmann, C. M.

Get full text

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging by Sheikhbahaei, Sara, Afshar-Oromieh, Ali, Eiber, Matthias, Solnes, Lilja B., Javadi, Mehrbod S., Ross, Ashley E., Pienta, Kenneth J., Allaf, Mohamad E., Haberkorn, Uwe, Pomper, Martin G., Gorin, Michael A., Rowe, Steven P.

Get full text

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study by van der Sijde, Fleur, Homs, Marjolein Y V, van Bekkum, Marlies L, van den Bosch, Thierry P P, Bosscha, Koop, Besselink, Marc G, Bonsing, Bert A, de Groot, Jan Willem B, Karsten, Thomas M, Groot Koerkamp, Bas, Haberkorn, Brigitte C M, Luelmo, Saskia A C, Mekenkamp, Leonie J M, Mustafa, Dana A M, Wilmink, Johanna W, van Eijck, Casper H J, Vietsch, Eveline E, On Behalf Of The Dutch Pancreatic Cancer Group

Get full text

Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions by Afshar-Oromieh, A., Malcher, A., Eder, M., Eisenhut, M., Linhart, H. G., Hadaschik, B. A., Holland-Letz, T., Giesel, F. L., Kratochwil, C., Haufe, S., Haberkorn, U., Zechmann, C. M.

Get full text

Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial) by Suker, Mustafa, Nuyttens, Joost J., Eskens, Ferry A.L.M., Haberkorn, Brigitte C.M., Coene, Peter-Paul L.O., van der Harst, Erwin, Bonsing, Bert A., Vahrmeijer, Alexander L., Mieog, J.Sven D., Jan Swijnenburg, Rutger, Roos, Daphne, Koerkamp, B.Groot, van Eijck, Casper H.J.

Get full text